Theravance Biopharma, Inc.·4

May 22, 6:15 PM ET

Shafer Bradford J 4

4 · Theravance Biopharma, Inc. · Filed May 22, 2019

Insider Transaction Report

Form 4
Period: 2019-05-20
Shafer Bradford J
Sr VP, Gen. Counsel, Secretary
Transactions
  • Tax Payment

    Ordinary Shares

    2019-05-20$19.84/sh2,488$49,362181,985 total
Footnotes (1)
  • [F1]Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -